Search Medical Condition
Please enter condition
Please choose location from dropdown

Ludwigsfelde, Germany Clinical Trials

A listing of Ludwigsfelde, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (91) clinical trials

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

Phase

6.7 miles

Learn More »

A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis

The study evaluates four dose levels of ABY-035, in comparison to placebo, in subjects with moderate to severe plaque psoriasis. The study consists of a four week screening period, three treatment periods and a four-week follow-up period. The treatment periods are: Randomized treatment; four dose levels and placebo. Biweekly (Q2W) ...

Phase

6.7 miles

Learn More »

A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study

This is a Phase II, multicenter, open-label extension (OLE) study to evaluate the long-term safety and efficacy of fenebrutinib in participants with Chronic Spontaneous Urticaria (CSU) who have completed the treatment period in a fenebrutinib CSU parent study. Participants may enroll in this OLE study at any time after completing ...

Phase

6.7 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).

Phase

6.82 miles

Learn More »

A Study to Assess Efficacy Safety Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

This is a Phase II, randomized, double-blind, placebo-controlled multicenter study of repeated doses of MOR106 administered as IV infusion. MOR106, is an antibody which is being developed as a treatment for diseases such as psoriasis and atopic dermatitis. An antibody is a protein that is made by the body in ...

Phase

6.82 miles

Learn More »

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

This trial is a randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy and safety of two oral doses of MP1032 (150 mg bid and 300 mg bid) in adult patients with moderate-to-severe chronic plaque psoriasis. The trial design consists of a 28-day screening period, a 12-week treatment period, and ...

Phase

6.82 miles

Learn More »

Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome

A growing number of cross-sectional studies is investigated the role of the human lipidome as a new biomarker for metabolic diseases. However, data on this issue is still sparse and especially interventional data is not available up to now. We intend to clarify, if the human lipidome is correlating with ...

Phase N/A

7.53 miles

Learn More »

Diabetes Nutrition Algorithm - Prediabetes

Prediabetes, defined by either impaired fasting glucose and/or impaired glucose tolerance, is a known high-risk condition predisposing to future diabetes mellitus type 2. Strategies to prevent progression from prediabetes to diabetes have been widely studied, however, without striking long-term effects of any kind of intervention (pharmacological, behavioral...). The investigators therefore ...

Phase N/A

7.53 miles

Learn More »

Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 2

Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft drinks may play a role in the development of diabetes. Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and even modulate incretin release. ...

Phase N/A

7.53 miles

Learn More »

Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus

Basic treatment of type 2 diabetes should focus on diet, physical activity and lifestyle. Nevertheless, in early and late stage of T2DM, lifestyle intervention is mostly substituted by pharmacological intervention, although lifestyle modification and dietary treatment would be favourable. The researchers therefore investigate dietary strategies such as low-carb diets and ...

Phase N/A

7.53 miles

Learn More »